Panel discussion live date: Tuesday 22 October 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. In this free panel discussion, our experts will provide insights into their own research using oligonucleotides, including the most common challenges encountered, key trends they have seen as the field develops and their opinions on the future outlook of the technology.
Webinar live date: Tuesday 29 October 2019 09:00 [PDT] 12:00 [EDT] 16:00 [GMT]. Learn about the sensitivity gains afforded by microflow chromatography vs high-flow and what potential this has for Met ID. See how this translates to stronger spectra in turn resulting in more metabolites being identified and characterized.
Thank you everyone who attended our live webinar ‘Exploratory biomarker testing: to qualify or validate the assay? The latest scientific and regulatory considerations for biomarker validation‘ in association with BioAgilytix, and to our speaker, Afshin Safavi, PhD for his time.
Webinar live date: Thursday 17 October, 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. A ‘tips and tricks’ approach to understanding and optimizing chromatography of oligonucleotides.
Webinar live date: Wednesday 3 October 2019 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. An overview of Gyrolab immunoassays and their utility in CMC target binding assays for batch release and stability assessment. Also, for preclinical and clinical PK analysis with a view to transferring assays to a CRO.
Webinar available on demand. In this free panel discussion, our experts will provide insights into their own research using ligand binding assays including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.
Mass Spectrometry (LC–MS/MS and LC–HRMS) approaches for bioanalysis of antibody–drug conjugates and applications will be presented.
Webinar available on demand. This webinar will discuss considerations for biomarker assay design and technology selection, including singleplex and multiplex ligand binding and immunometric assays, as well as optimization of pre-analytical factors and core assay performance expectations.
Webinar available on demand. Join us for a discussion on proactive, effective and efficient bioanalytical project management.
Webinar available to view on demand. Learn about the most advanced methods for quantitating and characterizing therapeutic oligonucleotides.
Webinar available to view on demand. Register for our exclusive panel discussion focusing on the new ICH M10 guideline on bioanalytical method validation.
Scientists from the University of Eastern Finland (Finland) and the University of Oulu (Finland) have published a study that demonstratesshows serum neurofilament levels could be used as a biomarker to discriminate frontotemporal dementia from psychiatric disorders.
A new study from the University of Texas at Austin (TX, USA) reports a desorption electrospray ionization mass spectrometry-based technique that could improve clinical thyroid cancer diagnosis.
LGC (Cambridge, UK) have become the first bioanalytical CRO in Europe to offer the Quanterix Simoa HD-X automated analyzer in a regulated environment.
Question 6: besides quantitative applications what else can hybrid assay technology do that will be important to future biotherapeutic development?
Question 5: what challenges do you experience when utilizing hybrid LBA/LC–MS assays in research and development? How do you avoid/overcome these?
Question 4: what questions can be answered by hybrid LBA/LC–MS assays over traditional bioanalytical techniques?